Inflammatory

161 drugs in development·97 companies·1 clinical trial

Drug Pipeline by Phase

Approved(45)

Drug	Company
amzeeq	FOAMIX PHARMACEUTICALS LTD. (FOMX)
Amzeeq	Journey Medical Corp (DERM)
Andrographolide	CHINA PHARMA HOLDINGS, INC. (CPHI)
arcalyst	X4 Pharmaceuticals, Inc (XFOR)
ARCALYST	Kiniksa Pharmaceuticals International, plc (KNSA)
azithromycin	SUNSET ISLAND GROUP (SUN)
brightening antioxidant serum pigment correcting formula	REGENEREX PHARMA, INC. (RGPX)
bromfenac	Amneal Pharmaceuticals, Inc. (AMRX)
bromfenac	Aptinyx Inc. (APTX)
caldolor	CUMBERLAND PHARMACEUTICALS INC (CPIX)
celecoxib	ACADIA PHARMACEUTICALS INC (ACAD)
celecoxib	Zomedica Corp. (ZOMDF)
celecoxib	Aptinyx Inc. (APTX)
celecoxib	Miromatrix Medical Inc. (MIRO)
celecoxib	AlphaTON Capital Corp (ATON)
clobetasol	Amneal Pharmaceuticals, Inc. (AMRX)
cutaquig	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
cuvitru	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
cyclosporine	Mylan II B.V. (MYL)
cyclosporine	Amneal Pharmaceuticals, Inc. (AMRX)
diclofenac	SUNSET ISLAND GROUP (SUN)
diclofenac	Aptinyx Inc. (APTX)
diclofenac	Miromatrix Medical Inc. (MIRO)
emrosi	Fortress Biotech Inc. (FBIO)
Emrosi	Journey Medical Corp (DERM)
esomeprazole magnesium	EXELIXIS, INC. (EXEL)
finacea	Silo Pharma, Inc. (SILO)
fluocinonide	Amneal Pharmaceuticals, Inc. (AMRX)
gammagard liquid	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
halcinonide	Mylan II B.V. (MYL)
hizentra	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
hyqvia	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
ilevro	HARROW, INC. (IMMY)
indomethacin	Mylan II B.V. (MYL)
indomethacin	Amneal Pharmaceuticals, Inc. (AMRX)
labeling	ACURA PHARMACEUTICALS, INC (ACUR)
lodonal	Biostax Corp. (BTAX)
meloxicam	Mylan II B.V. (MYL)
onetest for longevity	20/20 Biolabs Inc. (AIDX)
prednisone	DR REDDYS LABORATORIES LTD (RDY)
tobradex st	HARROW, INC. (IMMY)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)
triamcinolone acetonide	Miromatrix Medical Inc. (MIRO)
xembify	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
Zilxi	Journey Medical Corp (DERM)

Phase 3(30)

Drug	Company
Batoclimab	Immunovant, Inc. (IMVT)
bexobrutideg	Nurix Therapeutics, Inc. (NRIX)
bpx-01	TREX WIND-DOWN, INC. (TMBR)
claseprubart	Dianthus Therapeutics, Inc. /DE/ (DNTH)
Empasiprubart	ARGENX SE (ARGX)
Empasiprubart IV	ARGENX SE (ARGX)
gamunex-c	Grifols S.A. (GRFS)
imu-856	IMMUNIC, INC. (IMUX)
ivig	Sanofi (SNY)
IVIg	Sanofi (SNY)
IVIG	ARGENX SE (ARGX)
kite-439	Kite Pharma, Inc. (KITE)
kite-585	Kite Pharma, Inc. (KITE)
kite-718	Kite Pharma, Inc. (KITE)
kite-796	Kite Pharma, Inc. (KITE)
Neratinib	ENANTA PHARMACEUTICALS INC (ENTA)
Nipocalimab	Crinetics Pharmaceuticals, Inc. (CRNX)
nipocalimab sc-liv	GH Research PLC (GHRS)
Pertuzumab	Filana Therapeutics Inc. (FLNA)
remestemcel-l	Mesoblast Limited (MESO)
riliprubart	Sanofi (SNY)
riliprubart	Sanofi (SNY)
riliprubart prefilled pen	Sanofi (SNY)
Riliprubart Prefilled Pen	Sanofi (SNY)
tak-411	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-771	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-771	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-881	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-881	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
xembify	Grifols S.A. (GRFS)

Phase 2(24)

Drug	Company
ADX-631	Aldeyra Therapeutics, Inc. (ALDX)
daxdilimab	AMGEN INC (AMGN)
disc-0974	Disc Medicine, Inc. (IRON)
etokimab	ANAPTYSBIO, INC (ANAB)
fxr314	VivoSim Labs, INC. (VIVS)
imeroprubart	Immunovant, Inc. (IMVT)
isomyosamine	Q/C TECHNOLOGIES, INC. (QCLS)
KT-474/SAR444656	Kymera Therapeutics, Inc. (KYMR)
larazotide	9 METERS BIOPHARMA, INC. (NMTR)
morf-057	Morphic Holding, Inc. (MORF)
MORF-057	ELI LILLY & Co (LLY)
Neratinib	Filana Therapeutics Inc. (FLNA)
nipocalimab	GH Research PLC (GHRS)
Olaparib	Crinetics Pharmaceuticals, Inc. (CRNX)
pl8177	PALATIN TECHNOLOGIES INC (PTN)
prt2761	PORTOLA PHARMACEUTICALS INC (PTLA)
sar445088	Sanofi (SNY)
SER-287	Seres Therapeutics, Inc. (MCRB)
SPY120	Spyre Therapeutics, Inc. (SYRE)
SPY130	Spyre Therapeutics, Inc. (SYRE)
SPY230	Spyre Therapeutics, Inc. (SYRE)
tak-411	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
TAK-411	Merus N.V. (MRUS)
tti-109	Tvardi Therapeutics, Inc. (TVRD)

Phase 1(12)

Drug	Company
ANB101	ANAPTYSBIO, INC (ANAB)
CUE-401	Cue Biopharma, Inc. (CUE)
frtx-02	Fresh Tracks Therapeutics, Inc. (FRTX)
hyqvia	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
hyqvia	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
LP659	Longboard Pharmaceuticals, Inc. (LBPH)
ly3009104	ELI LILLY & Co (LLY)
prula-cel	Adicet Bio, Inc. (ACET)
rese-cel (resecabtagene autoleucel)	Cabaletta Bio, Inc. (CABA)
rt-111	Rani Therapeutics Holdings, Inc. (RANI)
sl-425	Shattuck Labs, Inc. (STTK)
wtx-921	Werewolf Therapeutics, Inc. (HOWL)

Preclinical(35)

Drug	Company
a2a agonists	REBUS HOLDINGS, INC. (NSPX)
ABS-101	Absci Corporation (ABSI)
ADX-743	Aldeyra Therapeutics, Inc. (ALDX)
anti-tnf mabs	Nexvet Biopharma plc (NVET)
atopidine	NEUROPATHIX, INC. (TYGS)
bt-002	BIORA THERAPEUTICS, INC. (BIOR)
covid-19 product candidate	Raphael Pharmaceutical Inc. (RAPH)
CPI-182	Corvus Pharmaceuticals, Inc. (CRVS)
cts-2090	Histogen Inc. (HSTO)
cts-2096	Histogen Inc. (HSTO)
ec2319	ENDOCYTE INC (ECYT)
EPS-3903	ENANTA PHARMACEUTICALS INC (ENTA)
eq504	Equillium, Inc. (EQ)
fin-524	Finch Therapeutics Group, Inc. (FNCH)
frtx-10	Fresh Tracks Therapeutics, Inc. (FRTX)
ht-003	Hoth Therapeutics, Inc. (HOTH)
ht-alz	Hoth Therapeutics, Inc. (HOTH)
imx-120	Immix Biopharma, Inc. (IMMX)
kind-509	Kindred Biosciences, Inc. (KIN)
KT-294	Kymera Therapeutics, Inc. (KYMR)
KT-295	Kymera Therapeutics, Inc. (KYMR)
kt-485/sar447971	Kymera Therapeutics, Inc. (KYMR)
lb-1	ProPhase Labs, Inc. (PRPH)
lb-2	ProPhase Labs, Inc. (PRPH)
linebacker	IMPACT BIOMEDICAL INC. (IBO)
linebacker-1	IMPACT BIOMEDICAL INC. (IBO)
linebacker-2	IMPACT BIOMEDICAL INC. (IBO)
lnc-001	REBUS HOLDINGS, INC. (NSPX)
man-dex	NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)
mira-55	MIRA PHARMACEUTICALS, INC. (MIRA)
pt002	Pandion Therapeutics, Inc. (PAND)
ser-603	Seres Therapeutics, Inc. (MCRB)
vbx-100	RANGE IMPACT, INC. (RNGE)
x.exosome	VITASPRING BIOMEDICAL CO. LTD. (NONE)
zegocractin (oral, preclinical administration)	CalciMedica, Inc. (CALC)

Unknown(9)

Drug	Company
cbdessence	FUTUREWORLD CORP. (FWDG)
diphenhydramine	Mesoblast Limited (MESO)
guselkumab	Innovation Pharmaceuticals Inc. (IPIX)
Halo-Lido	Citius Pharmaceuticals, Inc. (CTXR)
Icy Muscle Gel 500mg (Broad Spectrum topical)	Charlie's Holdings, Inc. (CHUC)
Next generation bispecific antibody platform	Celldex Therapeutics, Inc. (CLDX)
NX-0479 / GS-6791	Nurix Therapeutics, Inc. (NRIX)
Remicade	Merck & Co., Inc. (MRK)
Simponi	Merck & Co., Inc. (MRK)

BLA Filed(1)

Drug	Company
Icotyde	Protagonist Therapeutics, Inc (PTGX)

Phase 1/Phase 2(1)

Drug	Company
zugo-cel	CRISPR Therapeutics AG (CRSP)

Phase 2/Phase 3(2)

Drug	Company
caba-201 following preconditioning with fludarabine	Cabaletta Bio, Inc. (CABA)
imvt-1402	Roivant Sciences Ltd. (ROIV)

Phase 4(2)

Drug	Company
Dexmedetomidine infusion	COGNITION THERAPEUTICS INC (CGTX)
Efgartigimod PH20 SC	ARGENX SE (ARGX)

Compare drugs

amzeeq vs Andrographolide amzeeq vs arcalyst amzeeq vs azithromycin

Frequently asked questions

How many drugs are in development for Inflammatory?

BioSniper tracks 161 drugs in development for Inflammatory across 97 companies.

How many clinical trials target Inflammatory?

There are 1 clinical trial targeting Inflammatory tracked by BioSniper.

Deep-dive into Inflammatory

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis